Genome-wide association study identifies a susceptibility locus for thoracic aortic aneurysms and aortic dissections spanning FBN1 at 15q21.1
- PMID: 21909107
- PMCID: PMC3244938
- DOI: 10.1038/ng.934
Genome-wide association study identifies a susceptibility locus for thoracic aortic aneurysms and aortic dissections spanning FBN1 at 15q21.1
Abstract
Although thoracic aortic aneurysms and dissections (TAAD) can be inherited as a single-gene disorder, the genetic predisposition in the majority of affected people is poorly understood. In a multistage genome-wide association study (GWAS), we compared 765 individuals who had sporadic TAAD (STAAD) with 874 controls and identified common SNPs at a 15q21.1 locus that were associated with STAAD, with odds ratios of 1.6-1.8 that achieved genome-wide significance. We followed up 107 SNPs associated with STAAD with P < 1 × 10(-5) in the region, in two separate STAAD cohorts. The associated SNPs fall into a large region of linkage disequilibrium encompassing FBN1, which encodes fibrillin-1. FBN1 mutations cause Marfan syndrome, whose major cardiovascular complication is TAAD. This study shows that common genetic variants at 15q21.1 that probably act via FBN1 are associated with STAAD, suggesting a common pathogenesis of aortic disease in Marfan syndrome and STAAD.
Conflict of interest statement
The authors declare no competing financial interests.
Figures


Similar articles
-
The non-syndromic familial thoracic aortic aneurysms and dissections maps to 15q21 locus.BMC Med Genet. 2010 Oct 11;11:143. doi: 10.1186/1471-2350-11-143. BMC Med Genet. 2010. PMID: 20937124 Free PMC article.
-
Wide mutation spectrum and frequent variant Ala27Thr of FBN1 identified in a large cohort of Chinese patients with sporadic TAAD.Sci Rep. 2015 Aug 14;5:13115. doi: 10.1038/srep13115. Sci Rep. 2015. PMID: 26272055 Free PMC article.
-
Fibrillin-1 (FBN1) mutations in patients with thoracic aortic aneurysms.Circulation. 1996 Dec 1;94(11):2708-11. doi: 10.1161/01.cir.94.11.2708. Circulation. 1996. PMID: 8941093
-
Fibrillin-1 mutations in Marfan syndrome and other type-1 fibrillinopathies.Hum Mutat. 1997;10(6):415-23. doi: 10.1002/(SICI)1098-1004(1997)10:6<415::AID-HUMU1>3.0.CO;2-C. Hum Mutat. 1997. PMID: 9401003 Review.
-
Marfan syndrome. Part 1: pathophysiology and diagnosis.Nat Rev Cardiol. 2010 May;7(5):256-65. doi: 10.1038/nrcardio.2010.30. Epub 2010 Mar 30. Nat Rev Cardiol. 2010. PMID: 20351703 Review.
Cited by
-
Smooth muscle diversity from human pluripotent cells.Nat Biotechnol. 2012 Feb 8;30(2):152-4. doi: 10.1038/nbt.2117. Nat Biotechnol. 2012. PMID: 22318032 Free PMC article.
-
Aetiology and management of hereditary aortopathy.Nat Rev Cardiol. 2017 Apr;14(4):197-208. doi: 10.1038/nrcardio.2016.211. Epub 2017 Jan 19. Nat Rev Cardiol. 2017. PMID: 28102232 Review.
-
Genetics of human cardiovascular disease.Cell. 2012 Mar 16;148(6):1242-57. doi: 10.1016/j.cell.2012.03.001. Cell. 2012. PMID: 22424232 Free PMC article. Review.
-
Genome-wide analysis yields new loci associating with aortic valve stenosis.Nat Commun. 2018 Mar 7;9(1):987. doi: 10.1038/s41467-018-03252-6. Nat Commun. 2018. PMID: 29511194 Free PMC article.
-
Thoracic aortic dissection: genes, molecules, and the knife.Tex Heart Inst J. 2012;39(6):838-9. Tex Heart Inst J. 2012. PMID: 23304027 Free PMC article. Review. No abstract available.
References
-
- Milewicz DM, Dietz HC, Miller DC. Treatment of aortic disease in patients with Marfan syndrome. Circulation. 2005;111:e150–e157. - PubMed
-
- Guo DC, et al. Mutations in smooth muscle α-actin (ACTA2) lead to thoracic aortic aneurysms and dissections. Nat Genet. 2007;39:1488–1493. - PubMed
-
- Milewicz DM, et al. Genetic basis of thoracic aortic aneurysms and dissections: focus on smooth muscle cell contractile dysfunction. Annu Rev Genomics Hum Genet. 2008;9:283–302. - PubMed
-
- Zhu L, et al. Mutations in myosin heavy chain 11 cause a syndrome associating thoracic aortic aneurysm/aortic dissection and patent ductus arteriosus. Nat Genet. 2006;38:343–349. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- K08 HL080085/HL/NHLBI NIH HHS/United States
- UL1RR025758/RR/NCRR NIH HHS/United States
- R01 HL062594/HL/NHLBI NIH HHS/United States
- UL1RR024148/RR/NCRR NIH HHS/United States
- N01-HV-68199/HV/NHLBI NIH HHS/United States
- N01 HV068199/HL/NHLBI NIH HHS/United States
- K08-HL080085/HL/NHLBI NIH HHS/United States
- UL1 RR024148/RR/NCRR NIH HHS/United States
- UL1 RR025758/RR/NCRR NIH HHS/United States
- HHSN268201000048C/HL/NHLBI NIH HHS/United States
- P50 HL083794/HL/NHLBI NIH HHS/United States
- R01 HL109942/HL/NHLBI NIH HHS/United States
- R01-HL62594/HL/NHLBI NIH HHS/United States
- P50-HL083794/HL/NHLBI NIH HHS/United States
- T32 GM007526/GM/NIGMS NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical